Jane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN)

Jane Street Group LLC lowered its position in shares of Inogen, Inc. (NASDAQ:INGN) by 83.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 50,927 shares of the medical technology company’s stock after selling 250,473 shares during the quarter. Jane Street Group LLC owned 0.21% of Inogen worth $494,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. raised its position in Inogen by 312.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after buying an additional 132,287 shares during the last quarter. B. Riley Wealth Advisors Inc. purchased a new position in Inogen during the 2nd quarter worth $457,000. Divisadero Street Capital Management LP raised its position in Inogen by 682.3% during the 2nd quarter. Divisadero Street Capital Management LP now owns 2,346,766 shares of the medical technology company’s stock worth $19,079,000 after buying an additional 2,046,766 shares during the last quarter. State Street Corp grew its stake in shares of Inogen by 2.8% during the 3rd quarter. State Street Corp now owns 511,018 shares of the medical technology company’s stock worth $4,957,000 after purchasing an additional 14,054 shares during the period. Finally, Monaco Asset Management SAM acquired a new position in shares of Inogen during the 2nd quarter worth $610,000. Hedge funds and other institutional investors own 89.94% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on INGN. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research note on Friday, November 8th. StockNews.com cut shares of Inogen from a “buy” rating to a “hold” rating in a research note on Friday, December 20th.

Inogen Stock Up 4.7 %

NASDAQ:INGN opened at $9.62 on Monday. Inogen, Inc. has a fifty-two week low of $5.08 and a fifty-two week high of $13.33. The stock has a market cap of $229.13 million, a PE ratio of -4.28 and a beta of 1.02. The firm’s fifty day simple moving average is $9.39 and its 200-day simple moving average is $9.79.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.